A multifaceted quality improvement intervention to improve management of alcohol withdrawal on a general medicine ward: impact on benzodiazepine use

J Addict Dis. 2022 Apr-Jun;40(2):179-182. doi: 10.1080/10550887.2021.1960121. Epub 2021 Aug 6.

Abstract

Objective: To measure the effects of a quality improvement intervention on length of stay and benzodiazepine use among patients admitted for alcohol use disorder.

Methods: This retrospective cohort study was performed at the Salt Lake City Veterans Affairs Medical Center. Patients 18 years and older admitted to a general medical ward with a diagnosis of alcohol related disorders who were treated for alcohol withdrawal were included. The baseline cohort included patients admitted over 12 months. The post-intervention cohort included patients admitted over 12 months. Primary outcomes were total benzodiazepine dose and length of stay. Secondary outcomes included episodes of delirium tremens and seizures.

Results: Total benzodiazepine dose decreased significantly over the intervention period. Length of stay also decreased. No episodes of delirium tremens or seizures were observed.

Conclusions: A quality improvement intervention directed at general medicine inpatients admitted for alcohol withdrawal was associated with reductions in total benzodiazepine administration and length of stay.

Keywords: Alcohol withdrawal; CIWA; benzodiazepine; quality improvement.

MeSH terms

  • Alcohol Withdrawal Delirium* / complications
  • Alcohol Withdrawal Delirium* / drug therapy
  • Alcoholism* / drug therapy
  • Benzodiazepines / therapeutic use
  • Humans
  • Quality Improvement
  • Retrospective Studies
  • Seizures / complications
  • Seizures / drug therapy
  • Substance Withdrawal Syndrome* / drug therapy

Substances

  • Benzodiazepines